Boehringer Ingelheim - US | Leading Pharmaceutical Company

01.23.2012	Paul Fonteyne Named President and CEO of Boehringer Ingelheim USA Corporation
12.07.2011	Winners of the Making More Health Competition Bring Fresh Innovation to Solving Problems in Health
11.16.2011	Surveys reveal wide gaps in knowledge of genetic mutation testing exist between oncologists, nurses and cancer patients - For U.S. Media Only
11.14.2011	New Subanalyses of RE-LY ^® Trial Evaluate PRADAXA in Subsets of Patients with Non-Valvular Atrial Fibrillation
11.14.2011	Boehringer Ingelheim Executives Recognized for Supporting Diversity Initiatives